 | Up a level |
Haber, M., Murray, J., Gamble, L., Carnegie-Clark, A., Webber, H., Ruhle, M., Carter, D., Oberthur, A., Fischer, M., Ziegler, D., Marshall, G. M., Gurova, K., Burkhart, C., Purmal, A., Gudkov, A. V. and Norris, M. D. (2014). CBL0137, a novel NFkB suppressor and p53 activator, is highly effective in pre-clinical models of neuroblastoma. Eur. J. Cancer, 50. S. 135 - 136. OXFORD: ELSEVIER SCI LTD. ISSN 1879-0852
Schleiermacher, G., Mosseri, V., London, W. B., Maris, J. M., Brodeur, G. M., Attiyeh, E., Haber, M., Khan, J., Nakagawara, A., Speleman, F., Noguera, R., Tonini, G. P., Fischer, M., Ambros, I., Monclair, T., Matthay, K. K., Ambros, P., Cohn, S. L. and Pearson, A. D. J. (2012). Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG project. Br. J. Cancer, 107 (8). S. 1418 - 1423. LONDON: NATURE PUBLISHING GROUP. ISSN 0007-0920